Antibody Drug to Protect the Vulnerable From Covid Goes Unusednews2022-03-06T08:00:09+00:00March 6th, 2022|The New York Times|
Beneath a Covid Vaccine Debacle, 30 Years of Government Culpabilitynews2021-12-23T10:00:26+00:00December 23rd, 2021|The New York Times|
F.D.A. Authorizes AstraZeneca Drug for People With Immune Problemsnews2021-12-08T23:03:55+00:00December 8th, 2021|The New York Times|
AstraZeneca Says it Will Start Profiting From its Vaccinenews2021-11-13T05:15:23+00:00November 13th, 2021|The New York Times|
Covid Vaccines Produced in Africa Are Being Exported to Europenews2021-08-16T15:14:18+00:00August 16th, 2021|The New York Times|
U.S. Authorities Seek Documents From Troubled Covid Vaccine Manufacturernews2021-07-30T22:36:19+00:00July 30th, 2021|The New York Times|
Some Are Chasing Extra Vaccine Shots, While Scientists Debatenews2021-07-30T08:57:08+00:00July 30th, 2021|The New York Times|
Johnson & Johnson podría ser menos eficaz contra la variante deltanews2021-07-24T13:00:07+00:00July 24th, 2021|The New York Times|
J.&J. Vaccine May Be Less Effective Against Delta, Study Suggestsnews2021-07-20T21:20:49+00:00July 20th, 2021|The New York Times|
Citing the Delta Variant, Pfizer Will Pursue Booster Shots and a New Vaccinenews2021-07-09T01:51:11+00:00July 9th, 2021|The New York Times|
